IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions
暂无分享,去创建一个
C. Kayser | F. Soares | E. Sato | L. E. Andrade | F. L. Alberto | J. R. Carneiro | H. T. Fuzii | F. Alberto | H. Fuzii
[1] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[2] J. Toro,et al. Detection of type 1 cytokines in discoid lupus erythematosus. , 2000, Archives of dermatology.
[3] M. Meurer,et al. Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus , 2000, International journal of dermatology.
[4] F. Emmrich,et al. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-α in whole blood samples from patients with systemic lupus erythematosus , 1999, Lupus.
[5] L. Corral,et al. Immunomodulation by thalidomide and thalidomide analogues , 1999, Annals of the rheumatic diseases.
[6] Robert F. Bonner,et al. Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.
[7] G. Saed,et al. T-cell cytokine network in cutaneous lupus erythematosus. , 1997, Journal of the American Academy of Dermatology.
[8] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[9] J. Schröder,et al. Cytokine networks in the skin. , 1995, The Journal of investigative dermatology.
[10] D. Schadendorf,et al. Interleukin‐6 expression in the skin of patients with lupus erythematosus , 1995, Experimental dermatology.
[11] G. Saed,et al. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. , 1994, The Journal of investigative dermatology.
[12] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.
[13] P. Elias,et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.
[14] K. Weinberg,et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.
[15] T. Luger,et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.
[16] T. Luger,et al. Cytokine modulation of keratinocyte cytokines. , 1990, The Journal of investigative dermatology.
[17] A. Waage,et al. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. , 1988, Immunology.
[18] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[19] J. A. Robinson. Clinics , 1883, The Dental register.
[20] R. Lahita. Chapter 30 – The Clinical Presentation of Systemic Lupus Erythematosus , 2011 .
[21] L. Aarden,et al. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. , 1996, Scandinavian journal of rheumatology.
[22] I. Chaudry,et al. Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. , 1993, Immunology.